This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Oaktree Fund Administration, LLC. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Virginijus Valiunas
Introduction
Virginijus Valiunas is a notable inventor based in New York, NY (US). He has made significant strides in the field of medical technology, particularly in cancer treatment. His work focuses on the use of advanced cellular techniques to improve therapeutic outcomes.
Latest Patents
Virginijus Valiunas holds a patent for the "Use of mesenchymal lineage precursor cells or stem cells (MLPSCs) for delivery of oligonucleotides in the treatment of cancer." This innovative approach aims to enhance the efficacy of cancer therapies by utilizing stem cells for targeted delivery of therapeutic agents.
Career Highlights
Currently, Virginijus Valiunas is associated with Oaktree Fund Administration, LLC, where he applies his expertise in developing cutting-edge solutions for healthcare challenges. His career reflects a commitment to advancing medical science through innovative research and development.
Collaborations
He has collaborated with notable professionals in the field, including Sergey Doronin and Peter Brink. These partnerships have contributed to the advancement of his research and the successful implementation of his patented technologies.
Conclusion
Virginijus Valiunas exemplifies the spirit of innovation in the medical field, with his contributions paving the way for new treatment methodologies in cancer care. His work continues to inspire advancements in healthcare technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile